NCT03202212

Brief Summary

On line haemodiafiltration (OL-HDF) has been shown to improve intra-dialytic hemodynamics and cardiovascular outcomes. Several potential candidates of these beneficial effects have been explored. The aim of this study was to investigate the impact of mixed OL-HDF (mOL-HDF) on different circulating mediators of vascular dysfunction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Feb 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 3, 2014

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2014

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2014

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

June 8, 2017

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 28, 2017

Completed
Last Updated

June 29, 2017

Status Verified

June 1, 2017

Enrollment Period

7 days

First QC Date

June 8, 2017

Last Update Submit

June 27, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • RNA content of circulating particles

    Quantitative micro-RNA changes in plasmatic exosomes/microvesicles assessed by quantitative real-time PCR

    Study start (time 0) and study end (9 months)

Secondary Outcomes (2)

  • Circulating inflammatory markers

    All the study timepoints: time 0 and 3, 6, 9 months

  • RNA content of circulating particles

    All the study timepoints: time 0 and 3, 6, 9 months

Study Arms (2)

Mixed on-line hemodiafiltration

EXPERIMENTAL

Mixed on-line hemodiafiltration (mOL-HDF using FX 1000 CorDiax, Fresenius Medical Care, Bad Homburg, Germany), three sessions per week, four hours per session

Procedure: mixed on-line hemodiafiltration

High flux bicarbonate dialysis

ACTIVE COMPARATOR

Standard high flux bicarbonate dialysis with polysulfone membrane, three sessions per week, four hours per session

Procedure: High flux bicarbonate dialysis

Interventions

This is a mixed hemodepurative technique exploiting diffusion and convection through a semi-permeable membrane. Dialysis solution is not only interfacing with blood through the membrane (as in bicarbonate hemodialysis) but it is also mixed with it with a pre- and a post- filter dilution. The same amount of fluid added to the bloodstream is then removed within the filter through an appropriate negative pressure in the dialysis solution compartment and thanks a high permeability membrane. Patients will be treated three sessions per week, four hours per session

Mixed on-line hemodiafiltration

Standard high flux bicarbonate dialysis with polysulfone membrane, three sessions per week, four hours per session

High flux bicarbonate dialysis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • hemodialytic treatment from at least 6 months (3 times for week), blood flow rate during dialysis session (Qb) ≥250 ml/min using arterovenous fistula (AVF) or permanent central venous catheter (CVC), blood creatinine clearance \<5 ml/min, urine output \<500 ml/die.

You may not qualify if:

  • neoplastic diseases, autoimmune diseases, solid organ or bone marrow transplantation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Città della Salute e Della Scienza di Torino - Presidi CTO e Molinette

Torino, To, 10126, Italy

Location

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: 30 patients treated with a standard 3-time per week bicarbonate high-flux hemodialysis will be randomized 1:1 to continue the treatment or to be switched to mixed on-line hemodiafiltration for 9 months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator - Associate Professor of Nephrology

Study Record Dates

First Submitted

June 8, 2017

First Posted

June 28, 2017

Study Start

February 3, 2014

Primary Completion

February 10, 2014

Study Completion

November 11, 2014

Last Updated

June 29, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will share

At the time of registration the study was already completed. IPD data will be available upon request till the study publication, then data will be enclosed within the publication as supplementary material.

Locations